Tegretol · DIN 02194333 · 100 mg/5 mL · Oral suspension
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Tegretol · DIN 02194333
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-12-19
Health Canada: Marketed since 1999-06-10 · brand TEGRETOL SUSPENSION · ATC N03AF01 CARBAMAZEPINE · form Suspension · route Oral · ingredients CARBAMAZEPINE 100 MG/5ML · company Novartis pharmaceuticals canada inc · schedule Prescription
Ministry pays: $0.0578 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02194333)
Source record
DIN 02194333: Tegretol
Raw flags: sec3=Y
Item: 281200067; group id 423; item number 1047; lccId None; manufacturer id NOV
Source form: Oral Susp; strength: 100mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $0.1182; ministry $0.0578
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02194333
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19729
Interchangeable products
Taro-Carbamazepine · DIN 02367394 · $0.0578
Shortage status: not checked (no credentials)